ISOVOLEMIC HEMODILUTION IN CEREBRAL ISCHEMIA

Project: Research project

Description

We propose to study the effects of isovolemic hemodilution achieved by
phlebotomy and infusions of low molecular weight dextran in a dog model of
cerebral ischemia. Our hypothesis is that isovolemic hemodilution, by
reducing viscosity and thus improving microcirculation, will result in a
smaller infarct size when treated animals are compared with controls. One hundred dogs will be used over a three-year period. The animals will
be divided into two groups of 50 animals. All dogs will be splenectomized
1 week prior to initiation of the study. One group of animals (Group A)
will be studied acutely. In this group, 40 dogs will undergo temporary (6
hours) ligation of the distal internal carotid artery (ICA) and the
proximal middle cerebral artery (MCA). Of these animals, one-half will
have isovolemic hemodilution by phlebotomy and dextran injections
immediately after arterial ligation. In addition, 10 dogs will be
sham-operated. Of these, 5 will be subjected to isovolemic hemodilution
and 5 will not. Regional cerebral blood flow, as determined by
radionculide labeled microsperes, will be measured immediately after
arterial ligation. 1 hour after hemodilution or at an equivalent time in
non-hemodiluted animals, and one-half hour after termination of temporary
occlusion (removal of the arterial clips 6 hours after initial placement).
After the last injection of microspheres the animals will be perfused with
tetrazolium chloride (TTC) and then will be sacrificed. Volume of brain
infarction as determined by lack of staining with TTC will be estimated by
planimetry. The second group of 50 animals (Group B) will also be divided into 40 dogs
who will undergo temporary (6 hours) occlusion of the distal ICA and the
proximal MCA and 10 dogs who will be sham-operated. Again, one-half of the
dogs in each of these sub-groups will be subjected to isovolemic
hemodilution immediately after arterial occlusion. These animals in Group
B will not undergo blood flow measurements, but rather will be kept for a
week for daily neurologic observation and then will be perfused with
fluorescein and sacrificed at the end of the week for definitive
histopathologic examination of the brains to determine the size of
infarction. In all animals, hemodynamic and hematologic parameters to be
monitored and then compared and correlated will include the following:
intracranial pressure, systemic mean arterial pressure and pulse pressure,
arterial blood gases, hematocrit, fibrinogen level, blood viscosity,
central venous pressure, pulmonary artery pressure, cardiac output, blood
volume, bleeding time, prothrombin time, and partial thromboplastin time.
StatusFinished
Effective start/end date4/1/873/31/93

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health

Fingerprint

Hemodilution
Brain Ischemia
Dogs
Cerebrovascular Circulation
Regional Blood Flow
Middle Cerebral Artery Infarction
Colloids
Rabbits
Middle Cerebral Artery
Dextrans
Brain Infarction
Molecular Weight
Ligation
Hemodynamics
Fluorescein
Staining and Labeling
Internal Carotid Artery
Brain
Blood Viscosity

ASJC

  • Medicine(all)
  • Neuroscience(all)